Published in N Engl J Med on June 20, 1985
Regional variations in diagnostic practices. N Engl J Med (2010) 7.44
Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg (1998) 4.86
Clinical trials in head injury. J Neurotrauma (2002) 4.34
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Bias. J Epidemiol Community Health (2004) 3.85
Epidemiology and management of liver metastases from colorectal cancer. Ann Surg (2006) 3.37
The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol (2015) 3.29
Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective. Acta Neuropathol (2010) 2.06
Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev (2011) 1.95
Recent advances in the care of the patient with malignant melanoma. Ann Surg (1997) 1.92
Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011. Circulation (2014) 1.90
Minimally invasive oesophagectomy: current status and future direction. Surg Endosc (2011) 1.83
Multi-modality mediastinal staging for lung cancer among medicare beneficiaries. J Thorac Oncol (2009) 1.76
Pseudomyxoma peritonei. World J Gastrointest Oncol (2010) 1.76
Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location. World J Surg (2009) 1.73
Importance of metastatic lymph node ratio in non-metastatic, lymph node-invaded colon cancer: a clinical trial. Med Sci Monit (2014) 1.69
Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax (2006) 1.66
Hospital Incidence and Mortality Rates of Sepsis. Dtsch Arztebl Int (2016) 1.65
Steps to reduce favorable risk selection in medicare advantage largely succeeded, boding well for health insurance exchanges. Health Aff (Millwood) (2012) 1.60
Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg (1998) 1.50
Improved lymph node harvest from resected colon cancer specimens did not cause upstaging from TNM stage II to III. World J Surg (2011) 1.47
Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology. Gut (2007) 1.47
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer (2013) 1.42
Evidence for the Will Rogers phenomenon in migration of employees to managed care plans. J Gen Intern Med (1999) 1.41
Variation in the Contents of Sepsis Bundles and Quality Measures. A Systematic Review. Ann Am Thorac Soc (2015) 1.40
Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis. BMC Cancer (2009) 1.40
Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer (2002) 1.39
Paranasal sinus cancer: caveats and controversies. World J Surg (2003) 1.38
Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer. World J Surg (2012) 1.31
Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. Dis Colon Rectum (2008) 1.31
Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer. Ann Surg Oncol (2012) 1.29
Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg (2002) 1.29
Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators. Semin Oncol (2010) 1.28
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems. J Clin Oncol (2009) 1.27
Changes in long term prognosis for breast cancer in a Dutch cancer registry. BMJ (1994) 1.27
Opinion: why the variation in breast cancer survival in Europe? Breast Cancer Res (1999) 1.26
Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One (2012) 1.20
Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol (2004) 1.19
Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol (1999) 1.18
Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg (1994) 1.16
Gaming hospital-level pneumonia 30-day mortality and readmission measures by legitimate changes to diagnostic coding. Crit Care Med (2015) 1.15
The paired availability design for historical controls. BMC Med Res Methodol (2001) 1.13
How frequent is spontaneous remission of neuroblastomas? Implications for screening. Br J Cancer (1990) 1.10
Declining mortality from breast cancer in Yorkshire, 1983-1998: extent and causes. Br J Cancer (2004) 1.10
Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC). Eur J Nucl Med Mol Imaging (2009) 1.08
The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer (2012) 1.08
How successful is Medicare Advantage? Milbank Q (2014) 1.07
Immune cells: plastic players along colorectal cancer progression. J Cell Mol Med (2013) 1.07
The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer (2002) 1.07
Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res (2009) 1.06
Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer (2006) 1.04
Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg (2010) 1.03
Lymph node metastasis of gastric cancer. Cancers (Basel) (2011) 1.02
Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol (2012) 1.01
When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr (2014) 1.00
Prognosis in women with interval breast cancer: population based observational cohort study. BMJ (2012) 1.00
Impact of metastatic lymph node ratio in node-positive colorectal cancer. World J Gastrointest Surg (2010) 0.98
High ligation of the inferior mesenteric artery in rectal cancer surgery. Surg Today (2012) 0.97
Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994. Br J Cancer (2001) 0.97
Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement? J Am Coll Radiol (2012) 0.95
Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg (2003) 0.95
State-of-the-art management of nasopharyngeal carcinoma: current and future directions. Br J Cancer (2005) 0.95
Trends of population-based breast cancer survival in Germany and the US: decreasing discrepancies, but persistent survival gap of elderly patients in Germany. BMC Cancer (2012) 0.93
Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates. Cancer (2015) 0.93
Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials? Evid Based Complement Alternat Med (2007) 0.92
The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma. Ann Surg (1998) 0.91
When in doubt should we cut it out? The role of surgery in non-small cell lung cancer. Thorax (2006) 0.91
Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open (2012) 0.90
Quantifying the improvement in sepsis diagnosis, documentation, and coding: the marginal causal effect of year of hospitalization on sepsis diagnosis. Ann Epidemiol (2015) 0.90
Cancer survival in Britain. Cancer chemotherapy costs money. BMJ (1999) 0.90
Improved prognosis of breast cancer since 1970 in south-eastern Netherlands. Br J Cancer (1994) 0.90
Colorectal cancer and lymph nodes: the obsession with the number 12. World J Gastroenterol (2014) 0.90
Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. Chest (2014) 0.89
Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg (2011) 0.89
Efficacy of mediastinal lymph node dissection during thoracoscopic lobectomy. Ann Cardiothorac Surg (2012) 0.89
Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-1987. Br J Cancer (1990) 0.89
Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database. J Clin Oncol (2013) 0.89
Influence of stage at diagnosis on survival differences for rectal cancer in three European populations. Br J Cancer (1999) 0.88
Adjuvant therapy for gastric cancer: current and future directions. World J Gastroenterol (2014) 0.87
Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg (2010) 0.87
Pathological examination of 12 regional lymph nodes and long-term survival in stages I-III colon cancer patients: an analysis of 2,056 consecutive patients in two branches of same institution. Int J Colorectal Dis (2010) 0.87
Increase in incidence of disease due to diagnostic drift: primary liver cancer in Denmark, 1943-85. BMJ (1991) 0.86
Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France. Br J Cancer (1995) 0.86
Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation. Radiother Oncol (2010) 0.86
Cancer incidence and staging among American Indians in Oklahoma. J Okla State Med Assoc (2014) 0.86
Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol (2011) 0.86
Outcomes research in the development and evaluation of practice guidelines. BMC Health Serv Res (2002) 0.85
Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer. Br J Cancer (2011) 0.85
Bayesian approaches for comparative effectiveness research. Clin Trials (2011) 0.85
Evaluating prognostic factors: implications for measurement of health care outcome. J Epidemiol Community Health (1992) 0.85
Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008. Clin Exp Metastasis (2011) 0.84
Survival of invasive bladder cancer patients, 1998-2009; a central and northern Denmark population-based cohort study. Clin Epidemiol (2011) 0.84
Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient. Sarcoma (2015) 0.84
Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol (2009) 0.84
Judging quality of current septic shock definitions and criteria. Crit Care (2015) 0.84
Rationale and design of the European Polyp Surveillance (EPoS) trials. Endoscopy (2016) 0.84
A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol (1996) 20.25
Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med (1978) 11.42
A critical appraisal of the quality of quality-of-life measurements. JAMA (1994) 9.10
High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol (1990) 8.28
Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther (1981) 7.33
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol (1995) 6.94
The risk of determining risk with multivariable models. Ann Intern Med (1993) 6.45
Variability in radiologists' interpretations of mammograms. N Engl J Med (1994) 5.96
Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA (1995) 5.94
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest (1984) 5.19
Reviews of evidence regarding interventions to reduce alcohol-impaired driving. Am J Prev Med (2001) 4.99
Bicycle-associated head injuries and deaths in the United States from 1984 through 1988. How many are preventable? JAMA (1991) 4.76
Evaluation of clinical methods for rating dyspnea. Chest (1988) 4.12
Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med (1992) 3.64
Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med (2000) 3.40
Academic calculations versus clinical judgments: practicing physicians' use of quantitative measures of test accuracy. Am J Med (1998) 3.36
Problems of comorbidity in mortality after prostatectomy. JAMA (1992) 3.27
The International Health Program: the fifteen-year experience with Yale University's Internal Medicine Residency Program. Am J Trop Med Hyg (1999) 3.23
Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA (1999) 3.07
An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA (1979) 3.03
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis (1974) 3.01
The BCG controversy. A methodological and statistical reappraisal. JAMA (1983) 2.60
Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication. Clin Pharmacol Ther (1976) 2.53
An analysis of diagnostic reasoning. 3. The construction of clinical algorithms. Yale J Biol Med (1974) 2.44
Context bias. A problem in diagnostic radiology. JAMA (1996) 2.42
Scientific and clinical problems in indexes of functional disability. Ann Intern Med (1986) 2.41
The qualification period. J Clin Epidemiol (1991) 2.33
Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. J Clin Epidemiol (1995) 2.32
A simple procedure for general screening for functional disability in elderly patients. Ann Intern Med (1990) 2.32
Reviews of evidence regarding interventions to increase the use of safety belts. Am J Prev Med (2001) 2.28
Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study. Clin Pharmacol Ther (1971) 2.28
Claims of equivalence in medical research: are they supported by the evidence? Ann Intern Med (2000) 2.27
Coding ordinal independent variables in multiple regression analyses. Am J Epidemiol (1987) 2.15
A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.10
Methodologic standards and contradictory results in case-control research. Am J Med (1979) 2.09
Clinical biostatistics. XLIV. A survey of the research architecture used for publications in general medical journals. Clin Pharmacol Ther (1978) 2.07
T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics. Circulation (1982) 2.06
Clinical biostatistics. XLI. Hard science, soft data, and the challenges of choosing clinical variables in research. Clin Pharmacol Ther (1977) 2.04
Reviews of evidence regarding interventions to increase use of child safety seats. Am J Prev Med (2001) 2.03
The impact of ethnicity, family income, and parental education on children's health and use of health services. Am J Public Health (1999) 2.02
A collection of 56 topics with contradictory results in case-control research. Int J Epidemiol (1988) 2.02
A new clinical prognostic staging system for acute pancreatitis. Am J Med (1993) 2.02
An outbreak of cryptosporidiosis from fresh-pressed apple cider. JAMA (1994) 2.01
The 'chagrin factor' and qualitative decision analysis. Arch Intern Med (1985) 1.94
Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet (1979) 1.92
An additional basic science for clinical medicine: II. The limitations of randomized trials. Ann Intern Med (1983) 1.87
Clinical biostatistics. XXV. A survey of the statistical procedures in general medical journals. Clin Pharmacol Ther (1974) 1.87
Double standards, scientific methods, and epidemiologic research. N Engl J Med (1982) 1.81
Clinical biostatistics. XXXIX. The haze of Bayes, the aerial palaces of decision analysis, and the computerized Ouija board. Clin Pharmacol Ther (1977) 1.80
An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. JAMA (1979) 1.65
Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol (1990) 1.63
Measurement of lower limb alignment using long radiographs. J Bone Joint Surg Br (1991) 1.58
Current problems and future challenges in randomized clinical trials. Circulation (1984) 1.57
An analysis of Berkson's bias in case-control studies. J Chronic Dis (1986) 1.53
Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests. Clin Pharmacol Ther (1975) 1.52
Observer variability in the histopathologic diagnosis of lung cancer. Am Rev Respir Dis (1970) 1.51
The problems of the "problem-oriented medical record". Ann Intern Med (1973) 1.50
Complications of peripheral arteriography: a new system to identify patients at increased risk. J Vasc Surg (1995) 1.50
Clinical biostatistics. XX. The epidemiologic trohoc, the ablative risk ratio, and "retrospective" research. Clin Pharmacol Ther (1973) 1.50
The role of diagnostic inconsistency in changing rates of occurrence for coronary heart disease. J Clin Epidemiol (1992) 1.50
On white-coat effects and the electronic monitoring of compliance. Arch Intern Med (1990) 1.48
Joseph Goldberger: an unsung hero of American clinical epidemiology. Ann Intern Med (1994) 1.47
A bibliography of publications on observer variability (final installment). J Clin Epidemiol (1992) 1.47
An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. Yale J Biol Med (1973) 1.47
Clinical utility of endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (1997) 1.45
Bootstraps and jackknives: new, computer-intensive statistical tools that require no mathematical theories. J Investig Med (1998) 1.43
An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med (1983) 1.43
Discontinuation of antistreptococcal prophylaxis. A double-blind study in rheumatic patients free of heart disease. JAMA (1966) 1.42
A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. N Engl J Med (1969) 1.42
The problem of "protopathic bias" in case-control studies. Am J Med (1980) 1.41
On exorcizing the ghost of Gauss and the curse of Kelvin. MD Comput (1992) 1.39
The first reported outbreak of diarrheal illness associated with Cyclospora in the United States. Ann Intern Med (1995) 1.38
Does diagnostic accuracy in mammography depend on radiologists' experience? J Womens Health (1998) 1.37
Coffee and pancreatic cancer. The problems of etiologic science and epidemiologic case-control research. JAMA (1981) 1.37
Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size. Clin Pharmacol Ther (1975) 1.36
The 'epidemiologic necropsy'. Unexpected detections, demographic selections, and changing rates of lung cancer. JAMA (1987) 1.35
Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis (1979) 1.34
New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. JAMA (1989) 1.34
Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer (1996) 1.31
Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. Am Rev Respir Dis (1985) 1.30
An additional basic science for clinical medicine: I. The constraining fundamental paradigms. Ann Intern Med (1983) 1.29
Clinical effects of recurrent attacks of acute rheumatic fever: a prospective epidemiologic study of 105 episodes. J Chronic Dis (1967) 1.28
Monte Carlo methods in clinical research: applications in multivariable analysis. J Investig Med (1997) 1.28
Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicide. Clin Pharmacol Ther (1980) 1.27
Clinical biostatistics. XXVII. The derangements of the 'range of normal'. Clin Pharmacol Ther (1974) 1.27
Clinical biostatistics. II. Statistics versus science in design of experiments. Clin Pharmacol Ther (1970) 1.27
Tuberculosis in a correctional facility. Arch Intern Med (1993) 1.26
Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance. Clin Pharmacol Ther (1974) 1.26
What kind of basic science for clinical medicine? N Engl J Med (1970) 1.25
Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med (1978) 1.25
Ask patients what they want. Evaluation of individual complaints before total hip replacement. J Bone Joint Surg Br (1994) 1.23
Invidious comparisons and unmet clinical challenges. Am J Med (1992) 1.22